BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19172357)

  • 1. Temporal analysis of tumor heterogeneity and volume for cervical cancer treatment outcome prediction: preliminary evaluation.
    Prescott JW; Zhang D; Wang JZ; Mayr NA; Yuh WT; Saltz J; Gurcan M
    J Digit Imaging; 2010 Jun; 23(3):342-57. PubMed ID: 19172357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging.
    Mayr NA; Taoka T; Yuh WT; Denning LM; Zhen WK; Paulino AC; Gaston RC; Sorosky JI; Meeks SL; Walker JL; Mannel RS; Buatti JM
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):14-22. PubMed ID: 11777618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model.
    Mayr NA; Huang Z; Wang JZ; Lo SS; Fan JM; Grecula JC; Sammet S; Sammet CL; Jia G; Zhang J; Knopp MV; Yuh WT
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):972-9. PubMed ID: 22208967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging.
    Mayr NA; Yuh WT; Zheng J; Ehrhardt JC; Magnotta VA; Sorosky JI; Pelsang RE; Oberley LW; Hussey DH
    AJR Am J Roentgenol; 1998 Jan; 170(1):177-82. PubMed ID: 9423627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.
    Bowen SR; Yuh WTC; Hippe DS; Wu W; Partridge SC; Elias S; Jia G; Huang Z; Sandison GA; Nelson D; Knopp MV; Lo SS; Kinahan PE; Mayr NA
    J Magn Reson Imaging; 2018 May; 47(5):1388-1396. PubMed ID: 29044908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay.
    Mayr NA; Yuh WT; Magnotta VA; Ehrhardt JC; Wheeler JA; Sorosky JI; Davis CS; Wen BC; Martin DD; Pelsang RE; Buller RE; Oberley LW; Mellenberg DE; Hussey DH
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):623-33. PubMed ID: 8948347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer.
    Mayr NA; Wang JZ; Lo SS; Zhang D; Grecula JC; Lu L; Montebello JF; Fowler JM; Yuh WT
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):719-27. PubMed ID: 19632061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
    Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
    Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy.
    Wang JZ; Mayr NA; Zhang D; Li K; Grecula JC; Montebello JF; Lo SS; Yuh WT
    Cancer; 2010 Nov; 116(21):5093-101. PubMed ID: 20629080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer.
    Mayr NA; Yuh WT; Jajoura D; Wang JZ; Lo SS; Montebello JF; Porter K; Zhang D; McMeekin DS; Buatti JM
    Cancer; 2010 Feb; 116(4):903-12. PubMed ID: 20052727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can MRI predict local control rate of uterine cervical cancer immediately after radiation therapy?
    Saida T; Tanaka YO; Ohara K; Oki A; Sato T; Yoshikawa H; Minami M
    Magn Reson Med Sci; 2010; 9(3):141-8. PubMed ID: 20885087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervix.
    Mayr NA; Magnotta VA; Ehrhardt JC; Wheeler JA; Sorosky JI; Wen BC; Davis CS; Pelsang RE; Anderson B; Doornbos JF; Hussey DH; Yuh WT
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):915-24. PubMed ID: 8751400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer.
    Mayr NA; Yuh WT; Zheng J; Ehrhardt JC; Sorosky JI; Magnotta VA; Pelsang RE; Hussey DH
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):395-404. PubMed ID: 9308943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
    Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
    Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer.
    Lund KV; Simonsen TG; Hompland T; Kristensen GB; Rofstad EK
    Radiother Oncol; 2015 Jun; 115(3):379-85. PubMed ID: 25998804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of temporal parameters of DCE-MRI on the quantification of heterogeneity in tumor vascularization.
    Crombé A; Saut O; Guigui J; Italiano A; Buy X; Kind M
    J Magn Reson Imaging; 2019 Dec; 50(6):1773-1788. PubMed ID: 30980697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma grading using a machine-learning framework based on optimized features obtained from T
    Sengupta A; Ramaniharan AK; Gupta RK; Agarwal S; Singh A
    J Magn Reson Imaging; 2019 Oct; 50(4):1295-1306. PubMed ID: 30895704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model.
    Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
    Acta Oncol; 2019 Jun; 58(6):828-837. PubMed ID: 30810443
    [No Abstract]   [Full Text] [Related]  

  • 20. A volumetric analysis of GTV
    Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
    Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.